Department of Dermatology, The Second Xiangya Hospital of Central South University; Hunan Key Laboratory of Medical Epigenomics, Changsha, Hunan, 410011, China.
Department of Dermatology, The Second Xiangya Hospital of Central South University; Hunan Key Laboratory of Medical Epigenomics, Changsha, Hunan, 410011, China.
J Autoimmun. 2022 Apr;128:102811. doi: 10.1016/j.jaut.2022.102811. Epub 2022 Mar 9.
Although the contribution of aberrant CD4 T cell signaling to systemic lupus erythematosus (SLE) is well established, its role in cutaneous lupus erythematosus (CLE) skin is largely unknown. Because the rate of systemic manifestations varies in each subtype, resident memory CD4 T cells in lesions that are responsible for only skin-associated tissue responses may vary in each subtype. However, the role of CD4 tissue-resident memory T (CD4 Trm) cells in each CLE subtype remains unclear.
To analyze and compare CD4 Trm cells and absent in melanoma 2 (AIM2) identified by smart RNA sequencing (Smart-seq) in CD4 Trm cells from patients with acute CLE (ACLE), subacute CLE (SCLE), and localized discoid lupus erythematosus (localized DLE) lesions.
We performed Smart-seq to investigate differences in dermal CD4 Trm cells between patients with ACLE and normal controls (NCs). Multicolor immunohistochemistry was utilized to measure the levels of AIM2 in CD4 Trm cells present in the skin of 134 clinical patients, which included patients with localized DLE (n = 19), ACLE (n = 19), SCLE (n = 16), psoriasis (n = 12), rosacea (n = 17), lichen planus (n = 18), and annular granuloma (n = 15), as well as NCs (n = 18).
The Smart-seq data showed higher AIM2 expression in skin CD4 Trm cells from ACLE lesions than NCs (fold change >10, adjusted P < 0.05). AIM2 expression in CD4 Trm cells did not vary according to age or sex. AIM2 expression in CD4 Trm cells was significantly lower in patients with ACLE (6.38 ± 5.22) than localized DLE (179.41 ± 160.98, P < 0.0001) and SCLE (63.43 ± 62.27, P < 0.05). In an overall comparison of ACLE with localized DLE and SCLE, the receiver operating characteristic curve for AIM2 expression in CD4 Trm cells had a sensitivity of 100.00% and a specificity of 82.86% at a cutoff value of 18.26. In a comparison of ACLE with localized DLE, the sensitivity was 89.47%, and the specificity was 100.00% at a cutoff value of 12.26. In a comparison of ACLE with SCLE, the sensitivity was 100.00%, and the specificity was 75.00% at a cutoff value of 18.26.
The number of CD4 Trm cells is increased in lesions of SCLE and localized DLE compared to ACLE, suggesting that CD4 Trm cells may have a more crucial role in persistent lesions of SCLE and localized DLE. In addition, AIM2 expression in CD4 Trm cells discriminates patients with ACLE from those with localized DLE and SCLE.
虽然异常 CD4 T 细胞信号对系统性红斑狼疮(SLE)的贡献已得到充分证实,但它在皮肤红斑狼疮(CLE)皮肤中的作用在很大程度上尚不清楚。由于每种亚型的全身表现率不同,因此仅负责皮肤相关组织反应的病变中的驻留记忆 CD4 T 细胞在每种亚型中可能有所不同。然而,CD4 组织驻留记忆 T(CD4 Trm)细胞在每种 CLE 亚型中的作用仍不清楚。
通过智能 RNA 测序(Smart-seq)分析和比较急性 CLE(ACLE)、亚急性 CLE(SCLE)和局限性盘状红斑狼疮(localized DLE)病变中 CD4 Trm 细胞中的 CD4 Trm 细胞和缺失黑色素瘤 2(AIM2)。
我们进行了 Smart-seq 以研究 ACLE 患者和正常对照者(NCs)之间真皮 CD4 Trm 细胞之间的差异。多色免疫组化用于测量 134 例临床患者皮肤中存在的 CD4 Trm 细胞中的 AIM2 水平,这些患者包括局限性 DLE(n=19)、ACLE(n=19)、SCLE(n=16)、银屑病(n=12)、酒渣鼻(n=17)、扁平苔藓(n=18)和环状肉芽肿(n=15)以及 NCs(n=18)。
Smart-seq 数据显示,ACLE 病变皮肤 CD4 Trm 细胞中的 AIM2 表达高于 NC(倍数变化>10,调整 P<0.05)。AIM2 在 CD4 Trm 细胞中的表达与年龄或性别无关。与局限性 DLE(179.41±160.98,P<0.0001)和 SCLE(63.43±62.27,P<0.05)相比,ACLE 患者中 CD4 Trm 细胞中的 AIM2 表达明显更低。在对 ACLE 与局限性 DLE 和 SCLE 的总体比较中,AIM2 在 CD4 Trm 细胞中的表达的受试者工作特征曲线在截断值为 18.26 时具有 100.00%的敏感性和 82.86%的特异性。在 ACLE 与局限性 DLE 的比较中,截断值为 12.26 时,敏感性为 89.47%,特异性为 100.00%。在 ACLE 与 SCLE 的比较中,截断值为 18.26 时,敏感性为 100.00%,特异性为 75.00%。
与 ACLE 相比,SCLE 和局限性 DLE 病变中 CD4 Trm 细胞的数量增加,这表明 CD4 Trm 细胞在 SCLE 和局限性 DLE 的持续性病变中可能具有更重要的作用。此外,CD4 Trm 细胞中的 AIM2 表达可将 ACLE 患者与局限性 DLE 和 SCLE 患者区分开来。